News 2015
IPERGAY Study Examines Effectiveness of Nondaily PrEP
Jean-Michel Molina, M.D., Ph.D.
The first in a series of articles about the PrEP findings presented at the 2015 Conference on Retroviruses and Opportunistic Infections.
Read more: IPERGAY Study Examines Effectiveness of Nondaily PrEP
Major Program To Increase Access To Medications For People Living With HIV/AIDS Under Attack
340B drug discount program
Most people living with HIV/AIDS (PLWHA) probably have never heard of the federal 340B drug discount program but there's a good chance it has helped save their lives. The program allows Ryan White-funded clinics, state AIDS Drug Assistance Programs, and a long list of other safety-net hospitals and healthcare providers to buy outpatient prescription drugs at a discount. In turn, the "safety net providers" pass on the price break to patients in need and also use savings from the program to fund vital clinical services. HIV antiretrovirals are among the top medicines purchased through the program.
In This Issue
Activist Guy Anthony shares his story of getting diagnosed with HIV and then fighting to obtain the care and treatment he needed to become the leader and activist that he is today.
Guy Anthony: I Wanted to Live
Guy Anthony is a treatment-adherence program coordinator for Us Helping Us, People Into Living Inc. in Washington, D.C.
As I casually strolled down Hollywood Boulevard on an uneventful day in Los Angeles, I received a phone call from one of my best platonic friends. I answered, and the muffled voice on the other end blurted out three words that changed my life forever: "I have HIV."
Conversations from CROI 2015: Dr. Gina Brown and Dr. Ron Valdiserri on Microbicides, Women and HIV
Gina M. Brown, M.D., Coordinator, Women and Girls and Microbicides Research, Office of AIDS Research, National Institutes of Health
https://www.youtube.com/watch?v=aGebdYYLlGk
While at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, Dr. Ronald Valdiserri, Deputy Assistant Secretary for Health, Infectious Diseases, spoke with Dr. Gina Brown who leads women and girls and microbicide research activities at NIH's Office of AIDS Research. She observed that there were many interesting presentations at CROI this year designed to help us better understand and address the many differences and disparities that exist in HIV risk, prevention, care, and treatment among women and girls compared to men.